What Is TG Therapeutics, Inc. (TGTX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, TG Therapeutics, Inc.'s intrinsic value is estimated at $27.04, suggesting the stock is overvalued at its current price of $54.89. With 11 out of 13 models flagging downside (-50.7% average return), the market may be pricing in unsustainable growth. The most optimistic model, Markov DDM, places fair value at $68.36 (+24.5%), while Dynamic NAV — the most conservative — estimates $3.63 (-93.4%). This +117.9% gap reflects genuine analytical uncertainty about TG Therapeutics, Inc.'s intrinsic worth.
What Do the Models Say About TGTX?
13 of 13 models are currently active for TGTX. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates TGTX's intrinsic value at $16.28, implying -70.3% downside from the current price. See which stocks rank higher →
How Does TGTX Rank in Pharmaceutical Preparations?
Among 469 Pharmaceutical Preparations stocks, TGTX ranks #29 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places TGTX in the top tier.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, TG Therapeutics, Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating TGTX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is TGTX a Value Trap?
CirclFi's Value Trap algorithm assigns TGTX a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for TG Therapeutics, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, TG Therapeutics, Inc.'s fundamental quality profile registers 8.4/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +117.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TGTX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TGTX's 13 active models, average confidence is 37%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad